Evotec (ETR:EVT) Trading Down 1.3% – Here’s What Happened

Evotec SE (ETR:EVT) shares fell 1.3% during mid-day trading on Thursday . The stock traded as low as €6.30 ($6.84) and last traded at €6.32 ($6.86). 509,397 shares were traded during mid-day trading, a decline of 63% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.40 ($6.95).

Evotec Price Performance

The firm has a market capitalization of $1.11 billion, a P/E ratio of -6.49, a P/E/G ratio of 0.98 and a beta of 1.05. The stock’s fifty day simple moving average is €7.72 and its 200 day simple moving average is €7.64.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.